Ciproxifan
生物活性体外研究体内研究靶点
| 中文名称 | Ciproxifan |
|---|---|
| 中文同义词 | 环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯;环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯基]甲酮;化合物CIPROXIFAN |
| 英文名称 | Ciproxifan |
| 英文同义词 | CS-757;Ciproxifan (FUB-359);Cyclopropyl[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]methanone;FUB 359;Methanone, cyclopropyl[4-[3-(1H-iMidazol-4-yl)propoxy]phenyl]-;Ciproxifan, >=99%;Methanone, cyclopropyl[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]-;Ciproxifan USP/EP/BP |
| CAS号 | 184025-18-1 |
| 分子式 | C16H18N2O2 |
| 分子量 | 270.33 |
| EINECS号 | |
| 相关类别 | 神经信号;小分子抑制剂,天然产物;Inhibitors |
| Mol文件 | 184025-18-1.mol |
| 结构式 | ![]() |
Ciproxifan 性质
| 沸点 | 526.9±35.0 °C(Predicted) |
|---|---|
| 密度 | 1.231 |
| 储存条件 | 2-8°C |
| 溶解度 | 不溶于水 |
| 形态 | 固体 |
| 酸度系数(pKa) | 14.54±0.10(Predicted) |
| 颜色 | 白色 |
Ciproxifan 用途与合成方法
生物活性
Ciproxifan是一种高效的,选择性的histamin H3-receptor拮抗剂,IC50为9.2 nM,作用于其他受体亚型具有低亲和力。
体外研究
Ciproxifan inhibits [3H]HA release from synaptosomes with Ki of 0.5 nM. Ciproxifan inhibits the binding of [125I]iodoproxyfan at the brain H3 receptor with Ki of 0.7 nM. Ciproxifan displays high affinity at H3 receptor but shows low apparent affinity at other receptor subtypes as evaluated in functional tests on isolated organs (histamine H1 and H2, muscarinic M3, adrenergic α1D and β1, serotonin 5-HT1B, 5-HT2A, 5-HT3 and 5-HT4).
体内研究
Ciproxifan intravenously injected at dose of 1 mg/kg decreases the H3-receptor ligand concentration in serum in Male Swiss mice, with half-times of distribution phase of 13min and elimination phase of 87 min, respectively. Ciproxifan (1 mg/kg, p.o.) rises brain t-MeHA level rapidly in Male Swiss mice, being already significantly increased after 30 min, reaching a plateau between 90 and 180 min and still remaining enhanced after 270 min. Ciproxifan leads to ED50 values of 0.23 mg/kg in cerebral cortex, 0.28 mg/kg in striatum and 0.30 mg/kg in hypothalamus in Male Wistar rats. Ciproxifan (3 mg/kg, i.p.) significantly increases choice accuracy as evaluated in the five-choice task performed using a short stimulus duration. Ciproxifan (0.15-2 mg/kg, p.o.) induces marked signs of neocortical electroencephalogram activation manifested by enhanced fast-rhythms density and an almost total waking state in cats. Ciproxifan (10 mg/kg i.p.) enhances prepulse inhibition in the DBA/2 strain mice. Ciproxifan (3 mg/kg i.p.) alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease. Ciproxifan (3 mg/kg i.p.) improves accuracy and decreased impulsivity in adult male hooded Lister rats.
靶点
H 3receptor 9.2 nM (IC 50) |
安全信息
| 危险品标志 | Xn |
|---|---|
| 危险类别码 | 22-36/37/38-43 |
| 安全说明 | 26-36/37/39 |
| WGK Germany | 3 |
MSDS信息
Ciproxifan 上下游产品信息
上游原料
3-(1-三苯甲基-1H-咪唑-4-基)丙烷-1-醇4-羟基苯基环丙酮4-氟苯基环丙基甲酮4-氯-4'-氟苯丁酮



VIP会员
粤公网安备44196802000105号